CNBC Earnings

Home Depot and Walmart kick off first-quarter retail earnings next week.

It is the Swiss banking giant's first earnings report in the black since it completed the acquisition of fallen rival Credit Suisse.

Nintendo said it sold 15.7 million units of its flagship Switch console in the year ended March 2024, beating its own forecasts.

Aramco, which is the world's largest oil exporter, expects total dividends of $124.3 billion to be declared in 2024, it said.

Defense-technology and AI firm Palantir reported earnings that beat analyst expectations on revenue, but also issued weaker-than-hoped-for full-year guidance.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Berkshire Hathaway reported a huge year-over-year increase in operating earnings in the first quarter, while its cash holdings bubbled to record levels.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Sales of popular weight loss drug Wegovy more than doubled to 9.38 billion kroner.

Coinbase's quarterly results follow a big jump in the price of bitcoin from a year earlier, though the rally has stalled of late.

The consumer tech giant is as strong as ever, and we see positive catalysts ahead.

Block's earnings report comes during a slide in the stock price tied to reports that U.S. prosecutors were probing the company's compliance practices.

Apple CEO Tim Cook told CNBC that quarterly sales suffered from a difficult comparison to the year-earlier period.

Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.

Coterra Energy's production paid off in the first quarter, helping the oil-and-gas producer surpass Wall Street expectations.

Wayfair's sales fell in the first quarter, but the furniture retailer narrowed its losses by over $100 million after cutting 13% of its staff.

Peloton announced Thursday that CEO Barry McCarthy will be stepping down just over two years after he took over from founder John Foley.

The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.

Stanley Black & Decker turned in another solid quarter of execution on matters within management's control.

We're maintaining our 4 rating as we consider our next steps.